These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9621276)

  • 41. Periostin overexpression in collecting ducts accelerates renal cyst growth and fibrosis in polycystic kidney disease.
    Raman A; Parnell SC; Zhang Y; Reif GA; Dai Y; Khanna A; Daniel E; White C; Vivian JL; Wallace DP
    Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1695-F1707. PubMed ID: 30332313
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcriptome analysis of a rat PKD model: Importance of genes involved in extracellular matrix metabolism.
    Riera M; Burtey S; Fontés M
    Kidney Int; 2006 May; 69(9):1558-63. PubMed ID: 16541020
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increasing extracellular matrix collagen level and MMP activity induces cyst development in polycystic kidney disease.
    Liu B; Li C; Liu Z; Dai Z; Tao Y
    BMC Nephrol; 2012 Sep; 13():109. PubMed ID: 22963260
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aberrant epithelial cell growth in autosomal dominant polycystic kidney disease.
    Wilson PD
    Am J Kidney Dis; 1991 Jun; 17(6):634-7. PubMed ID: 2042637
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Azotemia and extrarenal manifestations in old female Han:SPRD (cy/+) rats.
    Kränzlin B; Schieren G; Gretz N
    Kidney Int; 1997 Apr; 51(4):1160-9. PubMed ID: 9083282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of Sodium-Glucose Cotransporter 2 with Dapagliflozin in Han: SPRD Rats with Polycystic Kidney Disease.
    Rodriguez D; Kapoor S; Edenhofer I; Segerer S; Riwanto M; Kipar A; Yang M; Mei C; Wüthrich RP
    Kidney Blood Press Res; 2015; 40(6):638-47. PubMed ID: 26698317
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Abnormal sodium pump distribution during renal tubulogenesis in congenital murine polycystic kidney disease.
    Avner ED; Sweeney WE; Nelson WJ
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7447-51. PubMed ID: 1323837
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of Aerobic Glycolysis Attenuates Disease Progression in Polycystic Kidney Disease.
    Riwanto M; Kapoor S; Rodriguez D; Edenhofer I; Segerer S; Wüthrich RP
    PLoS One; 2016; 11(1):e0146654. PubMed ID: 26752072
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of Notch3 in Renal Tubular Cells Leads to Progressive Cystic Kidney Disease.
    Djudjaj S; Kavvadas P; Prakoura N; Bülow RD; Migeon T; Placier S; Chadjichristos CE; Boor P; Chatziantoniou C
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055068
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells.
    Yamaguchi T; Hempson SJ; Reif GA; Hedge AM; Wallace DP
    J Am Soc Nephrol; 2006 Jan; 17(1):178-87. PubMed ID: 16319189
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Raf kinase inhibitor PLX5568 slows cyst proliferation in rat polycystic kidney disease but promotes renal and hepatic fibrosis.
    Buchholz B; Klanke B; Schley G; Bollag G; Tsai J; Kroening S; Yoshihara D; Wallace DP; Kraenzlin B; Gretz N; Hirth P; Eckardt KU; Bernhardt WM
    Nephrol Dial Transplant; 2011 Nov; 26(11):3458-65. PubMed ID: 21804086
    [TBL] [Abstract][Full Text] [Related]  

  • 52. VEGF receptor inhibition slows the progression of polycystic kidney disease.
    Tao Y; Kim J; Yin Y; Zafar I; Falk S; He Z; Faubel S; Schrier RW; Edelstein CL
    Kidney Int; 2007 Dec; 72(11):1358-66. PubMed ID: 17882148
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease.
    Spichtig D; Zhang H; Mohebbi N; Pavik I; Petzold K; Stange G; Saleh L; Edenhofer I; Segerer S; Biber J; Jaeger P; Serra AL; Wagner CA
    Kidney Int; 2014 Jun; 85(6):1340-50. PubMed ID: 24402093
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polycystic kidney disease: primary extracellular matrix abnormality or defective cellular differentiation?
    Calvet JP
    Kidney Int; 1993 Jan; 43(1):101-8. PubMed ID: 8433548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dietary conjugated linoleic acid reduces PGE2 release and interstitial injury in rat polycystic kidney disease.
    Ogborn MR; Nitschmann E; Bankovic-Calic N; Weiler HA; Fitzpatrick-Wong S; Aukema HM
    Kidney Int; 2003 Oct; 64(4):1214-21. PubMed ID: 12969139
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Overexpression of exogenous kidney-specific Ngal attenuates progressive cyst development and prolongs lifespan in a murine model of polycystic kidney disease.
    Wang E; Chiou YY; Jeng WY; Lin HK; Lin HH; Chin HJ; Leo Wang CK; Yu SS; Tsai SC; Chiang CY; Cheng PH; Lin HJ; Jiang ST; Chiu ST; Hsieh-Li HM
    Kidney Int; 2017 Feb; 91(2):412-422. PubMed ID: 28341240
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models.
    Chang MY; Parker E; Ibrahim S; Shortland JR; Nahas ME; Haylor JL; Ong AC
    Nephrol Dial Transplant; 2006 Aug; 21(8):2078-84. PubMed ID: 16720597
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elevated TGFbeta-Smad signalling in experimental Pkd1 models and human patients with polycystic kidney disease.
    Hassane S; Leonhard WN; van der Wal A; Hawinkels LJ; Lantinga-van Leeuwen IS; ten Dijke P; Breuning MH; de Heer E; Peters DJ
    J Pathol; 2010 Sep; 222(1):21-31. PubMed ID: 20549648
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Apico-basal polarity in polycystic kidney disease epithelia.
    Wilson PD
    Biochim Biophys Acta; 2011 Oct; 1812(10):1239-48. PubMed ID: 21658447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Flaxseed ameliorates interstitial nephritis in rat polycystic kidney disease.
    Ogborn MR; Nitschmann E; Weiler H; Leswick D; Bankovic-Calic N
    Kidney Int; 1999 Feb; 55(2):417-23. PubMed ID: 9987066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.